Your browser doesn't support javascript.
loading
2021 Update on Safety of Magnetic Resonance Imaging: Joint Statement From Canadian Cardiovascular Society/Canadian Society for Cardiovascular Magnetic Resonance/Canadian Heart Rhythm Society.
Ian Paterson, D; White, James A; Butler, Craig R; Connelly, Kim A; Guerra, Peter G; Hill, Michael D; James, Matthew T; Kirpalani, Anish; Lydell, Carmen P; Roifman, Idan; Sarak, Bradley; Sterns, Laurence D; Verma, Atul; Wan, Douglas; Crean, Andrew M; Grosse-Wortmann, Lars; Hanneman, Kate; Leipsic, Jonathon; Manlucu, Jaimie; Nguyen, Elsie T; Sandhu, Roopinder K; Villemaire, Christine; Wald, Rachel M; Windram, Jonathan.
Afiliación
  • Ian Paterson D; Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada. Electronic address: ip3@ualberta.ca.
  • White JA; Calgary Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada.
  • Butler CR; Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Connelly KA; St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Guerra PG; Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Québec, Canada.
  • Hill MD; Calgary Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada.
  • James MT; Calgary Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada.
  • Kirpalani A; St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Lydell CP; Calgary Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada.
  • Roifman I; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Sarak B; St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Sterns LD; Royal Jubilee Hospital, University of British Columbia, Victoria, British Columbia, Canada.
  • Verma A; Southlake Regional Health Centre, Newmarket, Ontario, Canada.
  • Wan D; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Crean AM; Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Grosse-Wortmann L; Doernbecher Children's Hospital, Oregon Health and Science University, Portland, Oregon, USA.
  • Hanneman K; Toronto General Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Leipsic J; St Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Manlucu J; London Health Sciences Centre, Western University, London, Ontario, Canada.
  • Nguyen ET; Doernbecher Children's Hospital, Oregon Health and Science University, Portland, Oregon, USA.
  • Sandhu RK; Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
  • Villemaire C; Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Québec, Canada.
  • Wald RM; Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Windram J; Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
Can J Cardiol ; 37(6): 835-847, 2021 06.
Article en En | MEDLINE | ID: mdl-34154798
Magnetic resonance imaging (MRI) is often considered the gold-standard test for characterizing cardiac as well as noncardiac structure and function. However, many patients with cardiac implantable electronic devices (CIEDs) and/or severe renal dysfunction are unable to undergo this test because of safety concerns. In the past 10 years, newer-generation CIEDs and gadolinium-based contrast agents (GBCAs) as well as coordinated care between imaging and heart rhythm device teams have mitigated risk to patients and improved access to MRI at many hospitals. The purpose of this statement is to review published data on safety of MRI in patients with conditional and nonconditional CIEDs in addition to patient risks from older and newer GBCAs. This statement was developed through multidisciplinary collaboration of pan-Canadian experts after a relevant and independent literature search by the Canadian Agency for Drugs and Technologies in Health. All recommendations align with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Key recommendations include: (1) the development of standardized protocols for patients with a CIED undergoing MRI; (2) patients with MRI nonconditional pacemakers and pacemaker dependency should be programmed to asynchronous mode and those with MRI nonconditional transvenous defibrillators should have tachycardia therapies turned off during the scan; and (3) macrocyclic or newer linear GBCAs should be used in preference to older GBCAs because of their better safety profile in patients at higher risk of nephrogenic systemic fibrosis.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Imagen por Resonancia Magnética / Enfermedades Cardiovasculares / Ajuste de Riesgo Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Can J Cardiol Asunto de la revista: CARDIOLOGIA Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pautas de la Práctica en Medicina / Imagen por Resonancia Magnética / Enfermedades Cardiovasculares / Ajuste de Riesgo Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Can J Cardiol Asunto de la revista: CARDIOLOGIA Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido